Sangeeta Bhatia

Dr. Sangeeta N.
Bhatia is an Independent Director at Vertex Pharmaceuticals, Inc., a Professor at Massachusetts Institute of Technology, a Co-Scientific Founder at Impilo Therapeutics, Inc., a Co-Scientific Founder at Port Therapeutics, Inc., a Scientific Advisory Board at Cristal Delivery BV, a Scientific Advisory Board at Maverick Therapeutics, Inc. and a Venture Partner at Catalio Capital Management LP.
She is on the Board of Directors at Satellite Biosciences, Inc. and Vertex Pharmaceuticals, Inc. Dr. Bhatia was previously employed as a Co-Founder by Matrisome Bio, Inc., a Co-Founder by Glympse Bio, Inc., a Founder by Hepregen Corp., a Professor by University of California San Diego, a Member by David H.
Koch Institute for Integrative Cancer Research, a Scientific Advisory Board by Lumicell, Inc., a Member by National Academy of Engineering, a Member by National Academy of Medicine (United States), a Member by National Academy of Sciences, a Member-Medicine Department by The Brigham & Women's Hospital, Inc., and a Member by The Broad Institute, Inc. She received her undergraduate degree from Brown University, a doctorate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.